Pacific Blue Cross aligns biosimilar drug policy with BC PharmaCare program

Tuesday, Nov 26, 2019

Recent transition will help balance plan member needs with the rising cost of health care.

The BC PharmaCare program has begun the transition of patients currently prescribed three brand name biologic drugs that are used to treat diabetes, arthritis, and certain types of skin conditions to their biosimilar drug.

Aligning our drug policy to BC PharmaCare and supporting their Biosimilars Initiative, allows plan sponsors to tailor benefit options to fit the needs of all plan members while ensuring that the medications offered by the plan are the right drugs at the right price.

Read the full article, published in Business in Vancouver: Healthy Decision on Biosimilar Drugs Creates Big Savings for B.C. Employer Benefit Plans